AshleyBelle Moisturizing Hand Sanitizer Vanilla Cascade
Ethyl Alcohol 70%
39 matching records for Cascade.
Ethyl Alcohol 70%
Ethyl Alcohol 70% V/V
Ethyl Alcohol 70%
Ethyl Alcohol 70% V/V
ALCOHOL
20250914
20250914
20250911
20250909
2025-02-27
2024-10-27
2020-12-09
A bioabsorbable device derived from animal collagen (e.g., bovine or porcine collagen) designed to produce a rapid haemostasis through platelet activation/aggregation (which initiates the haemostatic cascade leading to a fibrin clot) during a surgical proce...
A sterile, bioabsorbable device derived from animal collagen (e.g., bovine or porcine collagen) designed to produce a rapid haemostasis through platelet activation/aggregation (which initiates the haemostatic cascade leading to a fibrin clot) during a surgi...
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of complement cascade component C4d in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of complement cascade components C3 and/or C3c in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of complement cascade component C1q in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of complement cascade components C4 and/or C4c in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade components C3 and/or C3c in a clinical specimen, using a nephelometry/turbidimetry method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade components C4 and/or C4c in a clinical specimen, using a nephelometry/turbidimetry method.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of complement cascade components C3 and/or C3c in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of complement cascade components C3 and/or C3c in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of complement cascade components C4 and/or C4c in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of complement cascade components C4 and/or C4c in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of complement cascade component C1q in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade component C5 in a clinical specimen, using a precipitation/immunodiffusion method. It is useful in the investigation of condit...
A citric acid (citrate) formulation introduced into the extracorporeal circuit of a dialysis system to inhibit the coagulation of blood, typically during continuous renal replacement therapy (CRRT) - physiological dialysis performed over a 24-hour period or...
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade component C1 inhibitor in a clinical specimen, using a nephelometry/turbidimetry method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade component C1 inhibitor in a clinical specimen, using a precipitation/immunodiffusion method. It is used to assess C1 inhibitor...
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade component C1q in a clinical specimen, using an enzyme immunoassay (EIA) method.
A citric acid (citrate) formulation introduced into the extracorporeal circuit of a dialysis system to inhibit the coagulation of blood, typically during continuous renal replacement therapy (CRRT) - physiological dialysis performed over a 24-hour period or...
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement of complement cascade components C3 and/or C3c in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of complement cascade components C3 and/or C3c in a clinical specimen, using an enzyme immunoassay (EIA) method.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of complement cascade component C1 inhibitor in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of complement cascade component C1 inhibitor in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement of complement cascade component C2 in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of complement cascade component C2 in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of complement cascade component C2 in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of complement cascade component C3 proactivator in a clinical specimen.